LONDON, October 22 /PRNewswire-FirstCall/ -- The world’s leading peroxide hydrogen producer, Belgian based Solvay SA, has agreed a long term technical collaboration deal with RahuCat targeting the selective development of activated oxidation and bleaching processes.
The deal provides a platform for using Dragon activators and catalysts to improve peroxide hydrogen performance in three important markets. Development is aimed at peroxide market growth through improved operating economics, expansion into new applications and meeting future environmental regulation. The technical programme will use R&D facilities at both companies, initially based in Europe, but could expand into fast growing markets as application opportunities arise.
Commenting on the deal, RahuCat CEO, Paul Smith, welcomed the opportunity to work with the world’s leading player in peroxide chemistry and the chance to “combine real strengths in proven technologies for new and existing markets in all global regions”.
SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs some 29,000 people in 50 countries. In 2006 its consolidated sales amounted to EUR 9.4 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. Solvay is listed on the NYSE Euronext stock exchange in Brussels. Details are available at http://www.solvay.com
Rahu Catalytics Limited (“RahuCat”) develops and sells green catalyst and accelerator systems for a range of industrial applications, offering the environmentally attractive prospect of reduced power, water and chemical consumption and improved operating cost benefits. RahuCat is a technology spin out from Unilever PLC’s technology investment vehicle, Unilever Ventures Limited. Details are available at http://www.rahucat.com.
glenn.fletcher@rahucat.com
CONTACT: Contact: Glenn Fletcher, Rahu Catalytics Limited,
+44-7872-908232, glenn.fletcher@rahucat.com
